The antithrombotic effects of thrombocytopaenia and potentially decreased platelet function are (at least partially) compensated by prothrombotic changes, such as increased plasma levels of von Willebrand factor (VWF) and decreased levels of its regulator ADAMTS13.17 Here, VWF is linked to Thrombocytopenia.